Concord Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Concord Biotech Ltd. on BSE

Load latest

Concord Biotech Ltd.

24 Sep 2024

1632.00

3.14%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 30th September, 2024.

pdf

Concord Biotech Ltd.

24 Sep 2024

1632.00

3.14%

Company Update

Concord Biotech Ltd - 543960 - Clarification On Price Movement

BSE India

Clarification on Price Movement

pdf

Concord Biotech Ltd.

23 Sep 2024

1632.00

3.14%

Company Update

Concord Biotech Ltd - 543960 - Clarification sought from Concord Biotech Ltd

BSE India

The Exchange has sought clarification from Concord Biotech Ltd on September 23, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Concord Biotech Ltd.

12 Sep 2024

1632.00

3.14%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 19th September, 2024

pdf

Concord Biotech Ltd.

12 Sep 2024

1632.00

3.14%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 18th September, 2024.

pdf

Concord Biotech Ltd.

30 Aug 2024

1632.00

3.14%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.

pdf

Concord Biotech Ltd.

20 Aug 2024

1632.00

3.14%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The transcripts of the earning calls for the first quarter ended June 30, 2024 is enclosed herewith. kindly take the same into your records.

pdf

Concord Biotech Ltd.

12 Aug 2024

1632.00

3.14%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated August 07, 2024 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for the First Quarter ended on June 30, 2024, we wish to inform that the said Earning Call was held today at 03:30 PM (IST). Kindly take the above on records.

pdf

Concord Biotech Ltd.

10 Aug 2024

1632.00

3.14%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulation 2015, Investor Presentation on financial results for the first quarter ended June 30, 2024, is enclosed Kindly take the above on records

pdf

Concord Biotech Ltd.

10 Aug 2024

1632.00

3.14%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of the SEBI(LODR) Regulation, 2015, Please find enclosed herewith Extract of the unaudited standalone and consolidated Financial Results for the first quarter ended June 30, 2024,as published in the below Newspaper on August 10, 2024 Kindly take the above on records

pdf